177 related articles for article (PubMed ID: 14693616)
1. Reduction in [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced peripheral antinociception in diabetic rats: the role of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway.
Tasatargil A; Sadan G
Anesth Analg; 2004 Jan; 98(1):185-192. PubMed ID: 14693616
[TBL] [Abstract][Full Text] [Related]
2. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test.
Granados-Soto V; Rufino MO; Gomes Lopes LD; Ferreira SH
Eur J Pharmacol; 1997 Dec; 340(2-3):177-80. PubMed ID: 9537812
[TBL] [Abstract][Full Text] [Related]
5. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway.
Amarante LH; Duarte ID
Eur J Pharmacol; 2002 Nov; 454(1):19-23. PubMed ID: 12409000
[TBL] [Abstract][Full Text] [Related]
6. delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
Pacheco DF; Reis GM; Francischi JN; Castro MS; Perez AC; Duarte ID
Life Sci; 2005 Nov; 78(1):54-60. PubMed ID: 16135369
[TBL] [Abstract][Full Text] [Related]
7. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
Xu JY; Tseng LF
Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
[TBL] [Abstract][Full Text] [Related]
8. alpha(2)-Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the L-arginine/nitric oxide/cyclic GMP pathway in rat.
Romero TR; Duarte ID
Eur J Pharmacol; 2009 Jun; 613(1-3):64-7. PubMed ID: 19389395
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of protein kinase C in the attenuation of [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced antinociception in diabetic mice.
Ohsawa M; Kamei J
Eur J Pharmacol; 1997 Nov; 339(1):27-31. PubMed ID: 9450613
[TBL] [Abstract][Full Text] [Related]
10. Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice.
Ohsawa M; Mizoguchi H; Narita M; Kamei J; Nagase H; Tseng LF
Eur J Pharmacol; 2000 Jul; 401(1):55-8. PubMed ID: 10915837
[TBL] [Abstract][Full Text] [Related]
11. Participation of the components of L-arginine/nitric oxide/cGMP cascade by chemically-induced abdominal constriction in the mouse.
Abacioğlu N; Tunçtan B; Akbulut E; Cakici I
Life Sci; 2000; 67(10):1127-37. PubMed ID: 10954047
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in peripheral antinociception induced by N-palmitoyl-ethanolamine in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Cortes SF; Duarte ID
J Neurosci Res; 2012 Jul; 90(7):1474-9. PubMed ID: 22411529
[TBL] [Abstract][Full Text] [Related]
13. Involvement of L-arginine/NO/cGMP/K(ATP) channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Ghorbanzadeh B; Mansouri MT; Hemmati AA; Naghizadeh B; Mard SA; Rezaie A
Pharmacol Biochem Behav; 2014 Nov; 126():116-21. PubMed ID: 25278343
[TBL] [Abstract][Full Text] [Related]
14. The role of L-arginine/nitric oxide pathway in the antinociceptive activity of pyridoxine in mouse.
Abacioğlu N; Tunçtan B; Cakici I; Akbulut E; Uludağ O; Kanzik I
Arzneimittelforschung; 2001 Oct; 51(10):832-8. PubMed ID: 11715636
[TBL] [Abstract][Full Text] [Related]
15. Participation of the NO-cyclic GMP pathway in rofecoxib-induced antinociception.
Déciga-Campos M; López-Muñoz FJ
Proc West Pharmacol Soc; 2003; 46():165-7. PubMed ID: 14699919
[No Abstract] [Full Text] [Related]
16. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
Araiza-Saldaña CI; Reyes-García G; Bermúdez-Ocaña DY; Pérez-Severiano F; Granados-Soto V
Eur J Pharmacol; 2005 Dec; 527(1-3):60-70. PubMed ID: 16305795
[TBL] [Abstract][Full Text] [Related]
17. Antinociception after both peripheral and intrathecal injection of oxotremorine is modulated by spinal nitric oxide.
Machelska H; Pavone F; Capone F; Przewłocka B
Eur Neuropsychopharmacol; 1999 Mar; 9(3):213-7. PubMed ID: 10208290
[TBL] [Abstract][Full Text] [Related]
18. The antinociceptive activity of Muntingia calabura aqueous extract and the involvement of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in its observed activity in mice.
Zakaria ZA; Sulaiman MR; Jais AM; Somchit MN; Jayaraman KV; Balakhrisnan G; Abdullah FC
Fundam Clin Pharmacol; 2006 Aug; 20(4):365-72. PubMed ID: 16867020
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test.
Aguirre-Bañuelos P; Granados-Soto V
Eur J Pharmacol; 2000 Apr; 395(1):9-13. PubMed ID: 10781667
[TBL] [Abstract][Full Text] [Related]
20. Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats.
Chen SR; Pan HL
Anesthesiology; 2003 Jan; 98(1):217-22. PubMed ID: 12503000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
